2388
L. Menguy, F. Couty / Tetrahedron: Asymmetry 21 (2010) 2385–2389
in dry toluene (9.5 mL) was added 3,5-bis-(trifluoromethyl)phenyl
isothiocyanate (1.0 equiv, 228 mg). After the reaction mixture was
stirred for 30 min at room temperature, the reaction mixture was
concentrated in vacuo. The residue was purified by preparative
TLC (10:90, MeOH/CH2Cl2, Rf = 0.46) to give the desired thiourea
22 as pale yellow amorphous solid (169 mg, 41%); mp 84–86 °C.
mo-2-(2-nitro-vinyl)-thiophene (150 mg, 0.6 mmol) in dry toluene
(0.5 mL) and acetylacetone (2 equiv, 128 mg) under an argon atmo-
sphere. Upon consumption of the nitroolefin substrate after 6 h
(monitored by TLC), the reaction mixture was concentrated and
purified by preparative TLC (25:75, AcOEt/pentane, Rf = 0.10) to
yield a brown powder 1i (132 mg, 62%). mp 67 °C; ½a D25
¼ ꢀ30:0
ꢂ
½
a 2D5
ꢂ
¼ þ12:7 (c 1.2, CH2Cl2); FTIR mmax 3250, 3097, 2927, 2852,
1594, 1472, 1373, 1274, 1167, 1123, 881, 840, 726, 702,
681 cmꢀ1 1H NMR (300 MHz, CDCl3) d 7.42–7.09 (m, 8H), 5.22
(c 0.2, CH2Cl2); FTIR mmax 3080, 2922, 1726, 1547, 1430, 1361,
1251, 1142, 963, 795 cmꢀ1 1H NMR (300 MHz, CDCl3) d 6.89–6.87
.
.
(d, J = 4 Hz, 1H), 6.67–6.65 (d, J = 4 Hz, 1H), 4.65–4.62 (m, 2H),
4.41 (m, 1H), 4.34 (d, J = 10 Hz, 1H), 2.30 (s, 3H), 2.14 (s, 3H); 13C
NMR (75 MHz, CDCl3) d 201.2, 200.4, 140.1, 130.1, 127.6, 112.6,
78.0, 70.4, 38.5, 30.6, 29.9; HRMS (ESI) m/z calcd for C11H12BrNO4S
[M+Na]+: 355.9568, found: 355.9573. HPLC [CHIRALPAKÒ AD, 2-
propanol/heptane = 20/80, 0.8 mL/min, k = 244 nm, retention times:
(minor) 10.2 min, (major) 12.8 min].
(br s, 2H), 4.12 (m, 1H), 3.28 (dd, J = 10.9 Hz, J = 6.8 Hz, 1H), 3.10
(dd, J = 10.9 Hz, J = 8.8 Hz, 1H), 2.97 (dd, J = 6.6 Hz, J = 10.7 Hz
1H), 2.87 (m, 1H), 2.36 (s, 3H), 0.88 (d, J = 6.6 Hz, 3H); 13C NMR
(75 MHz, CDCl3) d 164.1, 150.2, 137.7, 132.6, 132.2, 131.8, 129.2,
128.9, 128.8, 127.8, 125.1, 122.0, 116.2, 58.5, 54.8, 52.6, 50.8,
32.9, 15.5; HRMS (ESI) m/z calcd for
C
21H21F6N3S [M+H]+:
462.1439, found: 462.1432.
4.3.3. (S)-Ethyl-2-(carboxyethyl)-4-nitro-3-phenylbutyrate 1a
Colorless needles.1a 1H NMR (300 MHz, CDCl3) d 7.42–7.10 (m,
5H), 4.93 (dd, J = 4.6, 13.1 Hz, 1H), 4.86 (dd, J = 9.2, 13.1 Hz, 1H),
4.33–4.15 (m, 3H), 4.00 (q, J = 7.2 Hz, 2H), 3.82 (d, J = 9.5 Hz, 1H),
1.25 (t, J = 7.2 Hz, 3H), 1.03 (t, J = 7.2 Hz, 3H); HPLC [CHIRALPAKÒ
AD-H, 2-propanol/heptane = 20/80, 0.8 mL/min, k = 213 nm, reten-
tion times: (major) 12.6 min, (minor) 34.8 min].
4.2.2. 1-((2R,3S,4R,5R)-1,5-Dimethyl-2,4-diphenylpyrrolidinic)-
3-(3,5-bis(trifluoromethyl)phenyl) thiourea 23
Under an argon atmosphere, to a solution of (2R,3S,4R,5R)-3-amino-
1,5-dimethyl-2,4-diphenyl-pyrrolidine 20 (118 mg, 0.45 mmol) in
toluene (6.6 mL) was added 3-(-bis(trifluoromethyl)phenyl
isothiocyanate (1.0 equiv, 122 mg). After the reaction mixture
was stirred for 30 min at room temperature, the reaction mixture
was concentrated in vacuo. The residue was purified by prepara-
tive TLC (30:70, AcOEt/pentane, Rf = 0.68) to give a viscous yellow
4.3.4. (R)-3-(2-Nitro-1-phenylethyl)pentane-2,4-dione 1b
White solid;6a mp 114–116 °C. 1H NMR (300 MHz, CDCl3): d
7.37–7.18 (m, 5H), 4.58–4.67 (m, 2H), 4.36–4.40 (d, J = 10.8 Hz,
1H), 4.21–4.28 (m, 1H), 2.30 (s, 3H), 1.94 (s, 3H); HPLC [CHIR-
ALPAKÒ AS-H, 2-propanol/heptane = 20/80, 0.8 mL/min, k = 215
nm, retention times: (minor) 15.0 min, (major) 24.9 min].
oil 23 (133 mg, 61%). ½a D25
ꢂ
¼ þ68:5 (c 0.2, CH2Cl2); FTIR
mmax 3300,
3031, 2932, 2780, 1525, 1380, 1171, 1125, 884, 846, 762, 699,
681 cmꢀ1 1H NMR (300 MHz, CDCl3) d 8.16 (br s, 1H), 7.49–7.15
.
(m, 13H), 5.80 (br s, 1H), 5.23 (br s, 1H), 4.08 (br s, 1H), 3.73 (br
s, 1H), 3.64 (m, 1H), 2.02 (s, 3H), 0.86 (d, 3H); 13C NMR (75 MHz,
CDCl3) d 180.1, 130.4, 128.7, 123.8, 119.1, 72.6, 65.1, 61.4, 51.8,
4.3.5. (R)-3-(1-Naphthalen-1-yl)-2-nitroethyl)pentane-2,4-
dione 1c
34.5, 15.1; HRMS (ESI) m/z calcd for
C
27H25F6N3S [M+H]+:
538.1752, found: 538.1732.
Yellow viscous oil.4a 1H NMR (300 MHz, CDCl3,) d 8.18–7.27 (m,
7H), 5.20 (m, 1H), 4.81 (dd, J = 12.0, J = 6.6 Hz, 1H), 4.75–4.68 (m,
2H), 2.31 (s, 3H), 1.86 (s, 3H); HPLC [CHIRALPAKÒ AS-H, 2-propa-
nol/heptane = 20/80, 0.8 mL/min, k = 215 nm, retention times:
(minor) 17.1 min, (major) 23.4 min].
4.3. General procedure for enantioselective Michael addition of
1,3 dicarbonyl compounds to nitroolefins
4.3.1. (R)-3-(1-(3-Nitrophenyl)-2-nitroethyl)pentane-2,4-dione
1g
4.3.6. (R)-3-(1-(2-Methoxyphenyl)-2-nitroethyl)pentane-2,4-
dione 1d
To a stirred solution of (2R,3S,4S)-2-(1-amino-methyl)-1,4-di-
methyl-3-phenyl-azetidine 12 (0.1 equiv, 12 mg) and 3,5-bis(tri-
fluoromethyl)phenyl isothiocyanate (0.1 equiv, 17 mg) in dry
toluene (0.9 mL) were added after 30 min a solution of (E)-1-ni-
tro-3-(2-nitro-vinyl)-benzene (123 mg, 0.6 mmol) in dry toluene
(0.5 mL) and acetylacetone (2 equiv, 128 mg) under an argon atmo-
sphere. Upon consumption of nitroolefin substrate in 24 h (moni-
tored by TLC), the reaction mixture was concentrated and purified
by preparative TLC (25:75, AcOEt/pentane, Rf = 0.20) to yield 1g as
Orange viscous oil.6d 1H NMR (300 MHz, CDCl3) d 7.29–7.25 (m,
1H), 7.09–7.07 (m, 1H), 6.88–6.92 (m, 2H), 4.82–4.75 (m, 1H),
4.61–4.49 (m, 3H), 3.89 (s, 3H)), 2.28 (s, 3H), 1.94 (s, 3H); HPLC
[CHIRALPAKÒ AS-H, 2-propanol/heptane = 20/80, 0.8 mL/min,
k = 215 nm, retention times: (minor) 14.7 min, (major) 15.0 min].
4.3.7. (R)-3-(1-(4-Methoxyphenyl)-2-nitroethyl)pentane-2,4-
dione 1e
an orange oil (147 mg, 79%). ½a D25
¼ ꢀ21:7 (c 1.3, CH2Cl2); FTIR mmax
ꢂ
Pale yellow solid;4a mp 117 °C. 1H NMR (300 MHz, CDCl3) d 7.10
(d, J = 8.5 Hz, 2H), 6.84 (d, J = 8.5 Hz, 2H), 4.61–4.57 (m, 2H), 4.35
(d, J = 11.0 Hz, 1H), 4.24–4.18 (m, 1H), 3.78 (s, 3H), 2.29 (s, 3H;
CH3), 1.95 (s, 3H); HPLC [CHIRALPAKÒ AD, 2-propanol/heptane =
20/80, 0.8 mL/min, k = 215 nm, retention times: (minor) 13.6 min,
(major) 19.9 min].
3069, 2963, 2919, 1716, 1548, 1527, 1349, 1250, 1171, 1142, 912,
738, 692 cmꢀ1 1H NMR (300 MHz, CDCl3) d 8.17–8.13 (m, 2H),
.
7.60–7.51 (m, 2H), 4.77–4.65 (m, 2H), 4.47 (d, J = 12 Hz, 1H), 4.40
(m, 1H), 2.33 (s, 3H), 2.05 (s, 3H); 13C NMR (75 MHz, CDCl3) d
200.9, 200.1, 148.5, 138.5, 134.5, 130.3, 123.5, 122.7, 77.4, 69.9,
42.2, 30.5, 30.1; HRMS (ESI) m/z calcd for C13H14N2O6 [M+Na]+:
317.0750, found: 317.075. HPLC [CHIRALPAKÒAS-H, 2-propanol/
heptane = 20/80, 0.8 mL/min, k = 215 nm, retention times: (minor)
31.0 min, (major) 50.2 min].
4.3.8. (R)-3-(1-(2-Nitrophenyl)-2-nitroethyl)pentane-2,4-dione
1f
Pale yellow solid;6c mp 112–114 °C. 1H NMR (300 MHz, CDCl3) d
7.93 (dd, J = 8.0, J = 1.4 Hz, 1H), 7.58–7.36 (m, 3H), 4.97 (dd,
J = 13.3, J = 7.1 Hz, 1H), 4.84 (dd, J = 13.3, J = 3.7 Hz, 1H), 4.73
(ddd, J = 8.7, J = 7.2, J = 3.7 Hz, 1H), 4.67 (d, J = 8.7 Hz, 1H), 2.31 (s,
3H), 2.13 (s, 3H); HPLC [CHIRALPAKÒ AS-H, 2-propanol/heptane =
20/80, 0.8 mL/min, k = 215 nm, retention times: (minor) 27.3 min,
(major) 28.4 min].
4.3.2. (R)-3-(1-(5-Bromothienyl)-2-nitroethyl)pentane-2,4-
dione 1i
To a stirred solution of (2R,3S,4S)-2-(1-amino-methyl)-1,4-di-
methyl-3-phenyl-azetidine 12 (0.1 equiv, 12 mg) and 3,5-bis-
(trifluoromethyl)phenyl isothiocyanate (0.1 equiv, 17 mg) in dry
toluene (0.9 mL) were added after 30 min a solution of (E)-5-bro-